Answers are grounded in this paper and cite their sources.
Background Serum butyrylcholinesterase (BChE) has been linked to metabolic dysfunction and hepatic steatosis. We examined associations of BChE activity and concentration with liver phenotypes and their incremental discriminatory value. Methods We analyzed 4,298 adults aged ≥ 20 years from NHANES 2021–2023 in a survey-weighted cross-sectional study. Multivariable regression assessed associations between serum BChE activity and controlled attenuation parameter (CAP), CAP-defined steatosis (≥ 274 dB/m), and liver stiffness measurement (LSM). Sensitivity analyses addressed metabolic adjustment, alternative steatosis definitions, and joint modeling of activity and concentration. Discrimination was evaluated beyond clinical risk factors. Results Per 1 survey-weighted standard deviation higher BChE activity, CAP was 8.90 dB/m higher (95% CI, 6.74–11.07), and steatosis prevalence was greater (prevalence ratio, 1.19; 95% CI, 1.14–1.23). Associations persisted across subgroups, alternative CAP thresholds, and a metabolic dysfunction-associated steatotic liver disease phenotype. Additional adjustment for HbA1c and lipids attenuated the CAP association (N = 4,218; β = 5.95 dB/m; 95% CI, 3.49–8.42). In a joint model (N = 4,297), activity remained associated with CAP after adjustment for concentration (β = 8.70; 95% CI, 4.45–12.95), whereas concentration showed little conditional association (β = 0.25; 95% CI, − 3.22 to 3.73). Adding activity beyond concentration increased weighted in-sample R² by 0.00578. Adding activity to clinical factors increased the area under the curve from 0.820 to 0.829 (difference, 0.009; 95% CI, 0.005–0.013). Adjusted LSM associations were not consistently significant, although exploratory spline analysis suggested nonlinearity. Conclusions Higher BChE activity was associated with CAP-measured hepatic steatosis, but added discrimination was modest. Cross-sectional findings do not establish causality or clinical utility.
No takes yet. Share an insight, caveat, or question.
Muhaisen et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: